Involvement of brain protein kinase C in nitrous oxide-induced antinociception in mice

Neuroscience

Volumn 140, Issue 1, 2006, Pages 227-233

  Ishikawa, M ^a   Matsushita, Y ^a   Abe, K ^a   Utsunomiya, I ^a   Hoshi, K ^a   Quock, R M ^b   Taguchi, K ^a  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^b Center for Integrated Biotechnology   (United States)

Author keywords

antinociception; mice; nitrous oxide; protein kinase C

Indexed keywords

BRAIN ENZYME; CALPHOSTIN C; CHELERYTHRINE; NITROUS OXIDE; PHORBOL DIBUTYRATE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; ANALGESIC AGENT; ENZYME INHIBITOR; NAPHTHALENE DERIVATIVE;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; ATTENUATION; BRAIN TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERANCE; ENZYME ACTIVATION; IMMUNOBLOTTING; LIGATION; LONG TERM EXPOSURE; MALE; MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; C57BL MOUSE; COMPARATIVE STUDY; ENZYMOLOGY; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; NOCICEPTIVE RECEPTOR; PAIN ASSESSMENT; PHYSIOLOGY; WESTERN BLOTTING;

ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MICE; MICE, INBRED C57BL; NAPHTHALENES; NITROUS OXIDE; NOCICEPTORS; PAIN MEASUREMENT; PHORBOL 12,13-DIBUTYRATE; PROTEIN KINASE C;

EID: 33746920907     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.02.001     Document Type: Article

References (51)

1. Berkowitz B.A., Finck A.D., and Ngai S.H. Nitrous oxide analgesia. reversal by naloxone and development of tolerance. J Pharmacol Exp Ther 203 (1977) 539-547
2. Berkowitz B.A., Finck A.D., Hynes M.D., and Ngai S.H. Tolerance to nitrous oxide analgesia in rats and mice. Anesthesiology 51 (1979) 309-312
3. Bie B., and Pan Z.Z. Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats. Mol Pain 1 (2005) 7
4. Cleary A.G., Ramanan A.V., Baildam E., Birch A., Sills J.A., and Davidson J.E. Nitrous oxide analgesia during intra-articular injection for juvenile idiopathic arthritis. Arch Dis Child 86 (2002) 416-418
5. Coe I.R., Yao L., Diamond I., and Gordon A.S. The role of protein kinase C in cellular tolerance to ethanol. J Biol Chem 46 (1996) 29468-29472
6. Cook H.L., Newsom R.S., Mensah E., Saeed M., James D., and Ffytche T.J. Entonox as an analgesic agent during panretinal photocoagulation. Br J Ophthalmol 86 (2002) 1107-1108
7. De A., Boyadjieva N., and Sarkar D.K. Role of protein kinase C in control of ethanol-modulated β-endorphine release from hypothalamic neurons in primary cultures. J Pharmacol Exp Ther 301 (2002) 119-128
8. Evers A.S., and Crowder C.M. General anesthetics. In: Hardman J.G., Limbird L.E., and Gilman A.G. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed (2001), McGraw-Hill, New York 337-365
9. Forbes G.M., and Collins B.J. Nitrous oxide for colonoscopy. A randomized controlled study. Gastrointest Endosc 51 (2000) 271-277
10. Fukura H., Kitani Y., Komiya Y., and Igarashi M. Nitrous oxide, but not xenon, affects the signaling in the neuronal growth cone. Prog Neuropsychopharmacol Biol Psychiatry 24 (2000) 1357-1368
11. 3 pathway is involved in muscarinic antinociception. Neuropsychopharmacology 28 (2003) 888-897
12. Gerhardt R.T., King K.M., and Wiegert R.S. Inhaled nitrous oxide versus placebo as an analgesic and anxiolytic adjunct to peripheral intravenous cannulation. Am J Emerg Med 19 (2001) 492-494
13. Giordano G., Sanchez-Perez A.M., Burgal M., Montoliu C., Costa L.G., and Felipo V. Chronic exposure to ammonia induces isoform-selective alterations in the intracellular distribution and NMDA receptor-mediated translocation of protein kinase C in cerebellar neurons in culture. J Neurochem 92 (2005) 143-157
14. Granados-Soto V., Kalcheva I., Hua X.-Y., Newton A., and Yaksh T.L. Spinal PKC activity and expression. role in tolerance produced by continuous spinal morphine infusion. Pain 85 (2000) 395-404
15. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 65 (2004) 443-452
16. 2C adrenoceptor subtypes in mice. Anesthesiology 90 (1999) 470-476
17. Hagihira S., Takenaka N., and Yoshiya I. Inhalation anesthetics suppress the expression of c-Fos protein evoked by noxious somatic stimulation in the deeper layer of the spinal cord in the rat. Brain Res 751 (1997) 124-130
18. Haley M.J., and McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol 12 (1957) 12-15
19. Harding T.A., and Gibson J.A. The use of inhaled nitrous oxide for flexible sigmoidoscopy. A placebo-controlled trial. Endoscopy 32 (2000) 457-460
20. Hemmings Jr. H.C., and Adamo A.I.B. Effects of halothane and propofol on purified brain protein kinase C activation. Anesthesiology 81 (1994) 147-155
21. Hemmings Jr. H.C., and Adamo A.I.B. Effect of halothane on conventional protein kinase C translocation and down-regulation in rat cerebrocortical synaptosomes. Br J Anaesth 78 (1997) 189-196
22. Henry R.J., Ishii M.M., and Quock R.M. Influence of chronic ethanol exposure on nitrous oxide analgesia in mice. J Dent Res 69 (1990) 1674-1677
23. 2O stimulates NOS enzyme activity in C57BL/6 but not DBA/2 mice. Brain Res 976 (2003) 262-263
24. Ishikawa M., and Quock R.M. Role of nitric-oxide synthase isoforms in nitrous oxide antinociception in mice. J Pharmacol Exp Ther 306 (2003) 484-489
25. Jackson D.L., and Johnson B.S. Inhalational and enteral conscious sedation for the adult dental patient. Dent Clin North Am 46 (2002) 781-802
26. Javed R.R., Dewey W.L., Smith P.A., and Smith F.L. PKC and PKA inhibitors reverse tolerance to morphine-induced hypothermia and supraspinal analgesia in mice. Eur J Pharmacol 492 (2004) 149-157
27. Jevtovic-Todorovic V., Todorovic S.M., Mennerick S., Powell S., Dikranian K., Benshoff N., Zorumski C.F., and Olney J.W. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 4 (1998) 460-463
28. v3.3 channels. Br J Pharmacol 144 (2005) 59-70
29. Kennedy R.M., and Luhmann J.D. Pharmacological management of pain and anxiety during emergency procedures in children. Paediatr Drugs 3 (2001) 337-354
30. Kingery W.S., Sawamura S., Agashe G.S., Davies M.F., Clark J.D., and Zimmer A. Enkephalin release and opioid receptor activation does not mediate the antinociceptive or sedative/hypnotic effects of nitrous oxide. Eur J Pharmacol 427 (2001) 27-35
31. Masood J., Shah N., Lanes T., Andrews H., Simpson P., and Barua J.M. Nitrous oxide (Entonox) inhalation and tolerance of transrectal ultrasound guided prostate biopsy. A double-blind randomized controlled study. J Urol 168 (2002) 116-120
32. McNulty S., Crouch M., Smart D., and Rumsby M. Differentiation of bipolar CG-4 line oligodendrocytes is associated with regulation of CREB, MAP kinase and PKC signaling pathways. Neurosci Res 41 (2001) 217-226
33. Mestek A., Hurley J.H., Bye L.S., Campbell A.D., Chen Y., Tisn M., Liu J., Schulman H., and Yu L. The human μ opioid receptor. modulation of functional desensitization by calcium/calmodulin-dependent protein kinase C. J Neurosci 15 (1995) 2396-2406
34. Narita M., Ohsawa M., Mizoguchi H., Kamei J., and Tseng L.F. Pretreatment with protein kinase C activator phorbol 12, 13-dibutyrate attenuates the antinociception induced by μ- but not ε-opioid receptor agonist in the mouse. Neuroscience 76 (1997) 291-298
35. Narita M., Ohsawa M., Mizoguchi H., Aoki T., Suzuki T., and Tseng L.F. Role of phosphatidylinositol-specific phospholipase C pathway in δ-opioid receptor-mediated antinociception in the mouse spinal cord. Neuroscience 99 (2000) 327-331
36. Narita M., Mizogushi H., Suzuki T., Narita M., Dun N.J., Imai S., Yajima Y., Nagase H., Suzuki T., and Tseng L.F. Enhanced μ-opioid responses in the spinal cord of mice lacking protein kinase Cγ isoform. J Biol Chem 276 (2001) 15409-15414
37. Quock R.M., and Graczak L.M. Influence of narcotic antagonist drugs upon nitrous oxide analgesia in mice. Brain Res 440 (1988) 35-41
38. 2O) antinociception. Brain Res 614 (1993) 52-56
39. Quock R.M., Curtis B.A., Reynolds B.J., and Mueller J.L. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice. J Pharmacol Exp Ther 267 (1993) 117-122
40. Quock R.M., Mueller J.L., Vaughn L.K., and Belknap J.K. Nitrous oxide antinociception in BXD recombinant inbred mouse strains and identification of quantitative trait loci. Brain Res 725 (1996) 23-29
41. Ramsay D.S., Leroux B.G., Rothen M., Prall C.W., Fiset L.O., and Woods S.C. Nitrous oxide analgesia in humans. acute and chronic tolerance. Pain 114 (2005) 19-28
42. ++ exchange in the neuroblastoma cell line SK-N-SH. J Pharmacol Exp Ther 280 (1997) 795-801
43. Rosen M.A. Nitrous oxide for relief of labor pain. A systematic review. Am J Obstet Gynecol 186 5 Suppl (2002) S110-S126
44. Rupreht J., Ukponmwan O.E., Dworacek B., Admiraal P.V., and Dzoljic M.R. Enkephalinase inhibition prevented tolerance to nitrous oxide analgesia in rat. Acta Anaesth Scand 28 (1984) 617-620
45. 2B adrenoceptors. J Neurosci 20 (2000) 9242-9251
46. Sawamura S., Obara M., Takeda K., Maze M., and Hanaoka K. Corticotropin-releasing factor mediates the antinociceptive action of nitrous oxide in rats. Anesthesiology 99 (2003) 708-715
47. Slater S.J., Cox K.J.A., Lombardi J.V., Ho C., Kelly M.B., Rubin E., and Stubbs C.D. Inhibition of protein kinase C by alcohols and anesthetics. Nature 364 (1993) 82-84
48. 3H]MK801 binding in the cerebral cortex, but not in the hippocampus of adult mice. Ann N Y Acad Sci 1053 (2005) 301-308
49. Sweitzer S.M., Wong S.M.E., Peters M.C., Mochly-Rosen D., Yeomans D.C., and Kendig J.J. Protein kinase C ε and γ. Involvement in formalin-induced nociception in neonatal rats. J Pharmacol Exp Ther 309 (2004) 616-625
50. 2+ ion concentration. Biochim Biophys Acta 1091 (1991) 401-404
51. 2+-calmodulin-dependent protein kinase II via MAP kinase signaling in cultured vascular smooth muscle cells. Anesthesiology 96 (2002) 148-154